1/ 3 af patienter kan forventes at få uønskede reaktioner efter behandling med tenofovirdisoproxilfumarat i kombination med andre antiretrovirale midler.
Approximately one third of patients can be expected to experience adverse reactions following treatment with tenofovir disoproxil fumarate in combination with other antiretroviral agents.